BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cell & Gene

Eisai Reclaims Full Rights to Farletuzumab Ecteribulin After Ending Collaboration with Bristol Myers Squibb

Eisai Co., Ltd. announced that it has agreed to end its global strategic collaboration with Bristol Myers Squibb for the co-development and c...

July 04, 2024 | News

IASO Biotechnology Secures NMPA Approval for IND Application of RD118 CAR-T Therapy Targeting GPRC5D for Relapsed/Refractory Multiple Myeloma

IASO Biotechnology , a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody pr...

July 01, 2024 | News

Advancing Cancer Care: The Promise and Potential of CAR-T Therapy

In an interaction with BioPharma APAC, Anuradha Rajapakse, Senior Director for Value & Access at Gilead and Kite Oncology, This discussion...

June 28, 2024 | Interaction

Porton Advanced Integrates MaxCyte cGMP-Grade Electroporation System into Cell Therapy Platform

Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as ...

June 26, 2024 | News

FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment

U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...

June 25, 2024 | News

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa

Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...

June 24, 2024 | News

Sarepta Therapeutics Secures FDA Approval for Expanded Use of ELEVIDYS in Duchenne Muscular Dystrophy Patients

Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today announced U.S. Food and Drug Administration (FDA) approv...

June 21, 2024 | News

GC Cell and Bifarma Forge Strategic Partnership to Pioneer Cell Therapy Market in Indonesia

GC Cell, a fully integrated cell and gene therapy pioneer, is proud to announce the establishment of an MOU for strategic partnership with Bifarma, a ...

June 20, 2024 | News

Thermo Fisher Scientific Webinar on Next-Generation T Cell AOF Formulation Medium

Click here to register Thermo Fisher Scientific is excited to announce an upcoming webinar titled "Supporting Efficacy and Scaling with a Next-Gen...

June 19, 2024 | News

Gilead and Kite Oncology Announce Cost-Effectiveness of Yescarta® in Large B-Cell Lymphoma in Singapore

Gilead and Kite Oncology announced new data from analyses of Yescarta® (axicabtagene ciloleucel), demonstrating its cost-effectiveness and budget impac...

June 14, 2024 | News

Thermo Fisher Scientific Transforms Cell Therapy Production with New Automated CO2 Incubators

To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ He...

June 13, 2024 | News

Asgard Therapeutics Selects Exothera for Clinical Manufacturing of Cancer Gene Therapy AT-108

Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it s...

June 12, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

June 11, 2024 | News

Alphamab Oncology and ArriVent BioPharma Forge Strategic Collaboration to Develop Novel Antibody Drug Conjugates

Alphamab Oncology announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. , a wholly-owned subsidiary of the Company, entered into a research an...

June 06, 2024 | News

Stay Connected